APA (7th ed.) Citation

MM, S., AHM, E., AM, S., M, I., MA, D., SHM, A., . . . IA, A. (2025). Synthesis and antimicrobial evaluation of a new hybrid bis-cyanoacrylamide-based-piperazine containing sulphamethoxazole moiety against rheumatoid arthritis-associated pathogens. Naunyn-Schmiedeberg's archives of pharmacology, 398(7), 8587. https://doi.org/10.1007/s00210-024-03780-7

Chicago Style (17th ed.) Citation

MM, Soliman, et al. "Synthesis and Antimicrobial Evaluation of a New Hybrid Bis-cyanoacrylamide-based-piperazine Containing Sulphamethoxazole Moiety Against Rheumatoid Arthritis-associated Pathogens." Naunyn-Schmiedeberg's Archives of Pharmacology 398, no. 7 (2025): 8587. https://doi.org/10.1007/s00210-024-03780-7.

MLA (9th ed.) Citation

MM, Soliman, et al. "Synthesis and Antimicrobial Evaluation of a New Hybrid Bis-cyanoacrylamide-based-piperazine Containing Sulphamethoxazole Moiety Against Rheumatoid Arthritis-associated Pathogens." Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 398, no. 7, 2025, p. 8587, https://doi.org/10.1007/s00210-024-03780-7.